- Home
- WRAP vs VRCA Comparison
WRAP vs VRCA Comparison
Compare WRAP & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WRAP | VRCA |
|---|---|---|
| Founded | 2016 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ordnance And Accessories | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.5M | 88.0M |
| IPO Year | 2017 | 2018 |
Fundamental Metrics
Financial Performance| Metric | WRAP | VRCA |
|---|---|---|
| Price | $1.23 | $3.51 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $13.83 |
| AVG Volume (30 Days) | ★ 515.9K | 48.5K |
| Earning Date | 11-11-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | $4,672,000.00 | ★ $35,577,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $60.79 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 3.66 | ★ 370.22 |
| 52 Week Low | $1.04 | $3.28 |
| 52 Week High | $6.00 | $9.82 |
Technical Indicators
Market Signals| Indicator | WRAP | VRCA |
|---|---|---|
| Relative Strength Index (RSI) | 40.14 | 35.26 |
| Support Level | $1.20 | $3.30 |
| Resistance Level | $1.68 | $5.94 |
| Average True Range (ATR) | 0.11 | 0.34 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 32.26 | 10.19 |
Price Performance
Historical ComparisonAbout WRAP Wrap Technologies Inc.
Wrap Technologies Inc is a public safety technology and services company that delivers safe and effective policing solutions to law enforcement and security personnel. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.